NNC 05-2090 hydrochloride |
Catalog No.GC11821 |
GABA uptake inhibitor
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 184845-18-9
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 184845-18-9 | SDF | |
Chemical Name | 1-(3-(9H-carbazol-9-yl)propyl)-4-(2-methoxyphenyl)piperidin-4-ol hydrochloride | ||
Canonical SMILES | COC1=CC=CC=C1C(CC2)(O)CCN2CCCN3C4=CC=CC=C4C5=CC=CC=C53.Cl | ||
Formula | C27H30N2O2.HCl | M.Wt | 451.01 |
Solubility | <5.64mg/ml in ethanol; <45.1mg/ml in DMSO | Storage | Desiccate at RT |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.2172 mL | 11.0862 mL | 22.1725 mL |
5 mM | 0.4434 mL | 2.2172 mL | 4.4345 mL |
10 mM | 0.2217 mL | 1.1086 mL | 2.2172 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC50675 Pomalidomide 4'-PEG1-acid
- GC10830 GS967
- GC15140 1-Oleoyl lysophosphatidic acid sodium salt
- GC42784 AMI-1 (sodium salt)
- GN10797 Tangeretin
- GN10380 Clinodiside A
- GC19188 HA15
- GC31436 HAEGTFTSD
- GC32919 Kevetrin hydrochloride (4-Isothioureidobutyronitrile hydrochloride)
- GC18004 MK-5172
- GC42480 5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide
- GC10950 IWR-1-endo
- GC50439 Peptide5
- GC37897 Vernakalant
- GC17251 QS 11
- GC18674 JWH 251
- GC40625 13,14-dihydro-15-keto-tetranor Prostaglandin D2
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *